The results of animal experiments with Su/Hx rats suggested that H-1337 administration suppressed the phosphorylation of MLC and mTOR in the SMCs of pulmonary arteries and attenuated pulmonary hypertension and pulmonary vascular remodeling. This evidence concerns the gene MTOR and pulmonary arterial hypertension.